Literature DB >> 2987395

Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.

K Taniguchi, S Urasawa, T Urasawa.   

Abstract

By employing three strains of cultivable human rotaviruses with different serotype specificity as immunizing antigens, we prepared 11 hybridomas which secreted neutralizing monoclonal antibodies against human rotaviruses. In neutralization tests with four strains of serotype 1, and three each of serotypes 2 and 3, the monoclonal antibodies showed different reactivity patterns: seven monoclonal antibodies reacted specifically with all strains of either serotype 1, 2 or 3 human rotavirus, but two showed strain-specific reactions; the remaining two were commonly reactive to various human rotavirus strains from each serotype but not to two non-human rotaviruses. By immunoprecipitation analysis, it was found that four serotype 2-specific and two commonly reactive antibodies were directed to VP3 (82000 mol. wt. protein) on the outer shell of the virus particles.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987395     DOI: 10.1099/0022-1317-66-5-1045

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  66 in total

1.  Serologic and genomic characterization of a G12 human rotavirus in Thailand.

Authors:  M Wakuda; S Nagashima; N Kobayashi; Y Pongsuwanna; K Taniguchi
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Identification of human and bovine rotavirus serotypes by polymerase chain reaction.

Authors:  K Taniguchi; F Wakasugi; Y Pongsuwanna; T Urasawa; S Ukae; S Chiba; S Urasawa
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

3.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Evidence for natural reassortants of human rotaviruses belonging to different genogroups.

Authors:  R L Ward; O Nakagomi; D R Knowlton; M M McNeal; T Nakagomi; J D Clemens; D A Sack; G M Schiff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

Authors:  N Kobayashi; K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

6.  Serotype-specific epitope(s) present on the VP8 subunit of rotavirus VP4 protein.

Authors:  G Larralde; B G Li; A Z Kapikian; M Gorziglia
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses.

Authors:  S Y Kang; L J Saif; K L Miller
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  VP4 monotype specificities among porcine rotavirus strains of the same VP4 serotype.

Authors:  F Liprandi; I Rodriguez; C Piña; G Larralde; M Gorziglia
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

Authors:  L Padilla-Noriega; R Werner-Eckert; E R Mackow; M Gorziglia; G Larralde; K Taniguchi; H B Greenberg
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.